Nasdaq formally approves transaction-related application; Company now in full compliance with Nasdaq listing requirements Company sets biotech spin-off for Q4 2026 as it sharpens focus on rare earths and critical minerals Board transitioning toward mining and capital markets expertise; annual shareholder meeting expected before year-end Sarfartoq acquisition recently closed following Greenland Government approval, adding flagship NdPr rare earth project with $2.05 billion high-case p…

You can read the full content here